These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents. Scheen AJ, Lefèbvre PJ. Diabetes Care; 2002 Jan; 25(1):247-8. PubMed ID: 11772929 [No Abstract] [Full Text] [Related]
9. Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, Van Weel C. Cochrane Database Syst Rev; 2005 Apr 18; 2005(2):CD003639. PubMed ID: 15846673 [Abstract] [Full Text] [Related]
11. [Current status of the treatment of type 2 diabetes mellitus. Alpha-glucosidase inhibitors]. Blicklé JF, Andres E, Brogard JM. Rev Med Interne; 1999 Aug 18; 20 Suppl 3():379s-383s. PubMed ID: 10480189 [Abstract] [Full Text] [Related]
12. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes]. Kitaoka H. Nihon Rinsho; 2002 Sep 18; 60 Suppl 9():464-9. PubMed ID: 12387035 [No Abstract] [Full Text] [Related]
13. Therapeutic options for the management of type 2 diabetes mellitus. Takiya L, Chawla S. Am J Manag Care; 2002 Nov 18; 8(11):1009-23; quiz 1024-7. PubMed ID: 12437315 [Abstract] [Full Text] [Related]